THSD7A expression in human cancer

Area of Science:

• Oncology
• Nephrology
• Immunology

Background:

• Thrombospondin Type-1 Domain containing 7A (THSD7A) is implicated in membranous nephropathy.
• THSD7A-associated malignancy was observed in a patient with THSD7A-associated membranous nephropathy.
• The potential role of THSD7A as a tumor antigen requires further investigation.

Purpose of the Study:

• To investigate the role of THSD7A as a potential tumor antigen.
• To evaluate THSD7A expression across a wide range of tumor types.
• To correlate THSD7A expression with tumor-specific markers and patient prognosis.

Main Methods:

• Immunohistochemistry was performed on over 20,000 tissue spots from more than 70 tumor entities using tissue microarrays.
• THSD7A expression patterns were analyzed in various neoplasms.
• Correlation between THSD7A expression and tumor-specific markers was assessed.

Main Results:

• THSD7A expression exhibited significant variability across different tumor types and staining patterns.
• Both increased and decreased THSD7A expression (compared to non-tumor tissue) were associated with tumor-specific markers.
• THSD7A expression levels demonstrated prognostic value in different tumor entities.

Conclusions:

• THSD7A is a potential tumor antigen with variable expression in neoplasms.
• Altered THSD7A expression is linked to tumor characteristics and prognosis.
• Further research is warranted to elucidate the role of THSD7A in tumor development and therapeutic strategies.